Amryt signs agreement to distribute Lojuxta into Russian Commonwealth and non-EU Balkan states
The company said this new agreement represents an increase of approximately 25% in the total number of addressable patients in the Amryt territories
More From BioPortfolio on "Amryt signs agreement to distribute Lojuxta into Russian Commonwealth and non-EU Balkan states"